Flashcards · Module 23
🦠 Critical Infections & Stewardship
4 of 4 cards published · read by the site’s author on 18 November 2026
*Clostridioides difficile* (C. diff): Why IV vancomycin does not work and enteral therapy does
Needs clinical review
The Patient:
An 81-year-old hospitalized for a fractured hip receives Ceftriaxone for a fever. Seven days later, she develops watery diarrhea (6 loose stools/day), cramping, and leukocytosis (WBC 18,000). Stool PCR is positive for C. difficile toxin.
The Big Pharmacology Trap (The Board Favorite!):
A student writes: "Patient has IV access, let's give IV Vancomycin for C. diff."
🚨 MISTAKE: Intravenous vancomycin has no effect on C. diff colitis, because it is not excreted into the colon; given enterally, vancomycin is concentrated in the gut lumen.
First-Line Treatment (IDSA / SHEA Guidelines):
🥇 Oral Fidaxomicin (200 mg PO BID for 10 days): suggested by IDSA/SHEA 2021 over oral vancomycin; similar initial response, fewer recurrences.
🥈 Oral Vancomycin (125 mg PO QID for 10 days): Highly effective in the gut lumen.
🔄 For Recurrent C. diff: Fecal Microbiota Transplantation (FMT) resolved it in 84% after a single FMT and 91% after repeat FMT (2020 meta-analysis).
Prevention Pearl:
Deprescribe unnecessary Proton Pump Inhibitors (PPIs): PPI use is associated with a higher risk of C. diff infection and of its recurrence (gastric acid is a natural barrier against ingested pathogens).
Sources checked (6) · 17 November 2026
- 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. (2019)
- Antibiotic Therapy in Acute Infectious Diarrhea and Clostridioides difficile Infection: Clinical Indications, Antimicrobial Stewardship, and Evidence Gaps (2026)
- Vancomycin Insights: An Update on Mechanism, Activity, Toxicity, Resistance, and Novel Drug Delivery Systems (2025)
- Barriers to Diagnosis and Treatment of Clostridioides difficile Infection: A Narrative Review (2026)
- Faecal microbiota transplantation for recurrent Clostridioides difficile infection: An updated systematic review and meta-analysis. (2020)
- Impact of Gastric Acid Suppression on Clostridioides difficile Infection: A Systematic Review (2026)
Geriatric Sepsis: The Hypothermia Sign and Individualised Fluids
Needs clinical review
The Atypical Presentation:
An 85-year-old with pneumonia is admitted. His temperature is 35.4°C (95.7°F). A resident says: "At least he doesn't have sepsis, he has no fever." WRONG! Fever is often absent in older adults with sepsis.
The Physiology of Hypothermia in Aging:
Common medicines (beta-blockers, antipsychotics, sedatives) can lower body temperature.
Sarcopenia: less muscle mass and a lower basal metabolic rate, a main driver of low body temperature in older people.
Fever is often absent; confusion, delirium, fatigue and decline in function are more frequent.
🚨 The Hypothermia Sign: in septic shock, a temperature <36 °C at inclusion was linked to higher mortality (adjusted HR 1.92); persistent hypothermia carried the highest 90-day mortality (78.3%, HR 2.83).
The Resuscitation Dilemma:
The Surviving Sepsis Campaign recommends at least 30 mL/kg of IV crystalloid within the first 3 hours for sepsis-induced hypoperfusion or septic shock.
In septic patients with heart failure, a 2022 meta-analysis found no increase in adverse events from the recommended bolus, and one study found 12% lower mortality for each 250 mL given in the first 6 hours.
Individualise: septic patients with HFpEF may benefit from a more individualised approach to fluid resuscitation, using tools that assess fluid responsiveness.
Sources checked (5) · 17 November 2026
- Relation between initial hypothermia, course of the hypothermia and mortality in patients with septic shock: a post-hoc analysis of the SEPSISPAM randomized trial (2026)
- Sepsis in Frail Older Adults: Tailored Antimicrobial Stewardship and Individualized Care Approach (2026)
- Approach to Low Body Temperature or Mild Hypothermia in the Geriatric Population: A Narrative Review (2026)
- Fluids in sepsis (2026)
- Evidence-based fluid resuscitation of the septic HFpEF patient: A narrative review of the literature (2026)
Note: Vasopressors such as norepinephrine reduce venous capacitance and increase stressed blood volume to restore perfusion pressure. (Fluids in sepsis (2026))
Diabetic Foot Infections & The "Probe-to-Bone" Test: Detecting osteomyelitis at the bedside
Needs clinical review
The Clinical Encounter:
An 74-year-old diabetic man has a chronic, deep ulcer under the head of his first metatarsal. How do you find out if the underlying bone is infected without waiting for an MRI?
The "Probe-to-Bone" (PTB) Test:
Take a sterile, blunt probe.
Gently insert it into the center of the open ulcer.
If you feel a hard or gritty surface, the test is POSITIVE.
A positive PTB test points strongly to osteomyelitis: specificity was 85% in the first study and 91% in later ones.
The Culture Trap:
❌ Avoid superficial wound swabs: they may grow colonising organisms and miss the pathogens in deeper infected tissue.
✅ The Correct Method: Debride the ulcer bed and obtain a deep tissue curettage or bone biopsy for true microbiological culture.
Microbiology of Chronic Wounds:
Chronic diabetic foot infections are polymicrobial:
Gram-positive cocci (Staph aureus, including MRSA; streptococci)
Gram-negative bacilli (Pseudomonas, Proteus, E. coli)
Anaerobes, in selected chronic, deep, necrotic or ischaemic wounds
Sources checked (2) · 17 November 2026
Note: In hospitalized cohorts with high pretest probability, probing to bone has a high positive predictive value for osteomyelitis. (Pilot randomised controlled trial of probe to bone diabetic foot ulcer therapy (PROBE-DFU trial) – Study protocol (2026))
Infective Endocarditis in Older Adults: Atypical presentations and the colon cancer link
Needs clinical review
The Paradigm Shift:
The median age of patients with infective endocarditis is now nearly 73 years, and degenerative valve disease has risen as rheumatic heart disease has declined.
Why It's Missed:
Classical peripheral signs (Osler nodes, Janeway lesions, splinter haemorrhages) are less common.
A new or changing murmur is still found in about 85% of patients.
Non-specific symptoms are common: fatigue (25–80%), anorexia (25–50%), weight loss (25–35%).
The Two Classic Pathogens:
Enterococcus faecalis: increasingly important in older and hospitalised patients with genitourinary or gastrointestinal disease.
Streptococcus gallolyticus (Streptococcus bovis):
🚨 If blood cultures grow S. gallolyticus, a COLONOSCOPY is recommended.
Bacteraemia with this group (S. bovis/equinus complex) carries a 3.73-fold risk of underlying colorectal cancer; a link with adenomas was not significant (2023 meta-analysis).